Today's Latest Price: $49.52 USD

0.24 (-0.48%)

Updated Jan 15 4:00pm

Add IMAB to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 239 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

I-Mab (IMAB) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering IMAB.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
6 $58.09 $51.03 $54.32 $49.76 9.16%

IMAB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IMAB as an investment opportunity.

  • The average analyst price target of IMAB is greater than 95.16% of stocks in the micro market cap category.
  • IMAB has a greater number of analysts covering the stock than 94.29% of stocks in the micro market cap category.
  • The variance in analysts' estimates of IMAB is lower than 83.38% of Pharmaceutical Products stocks.
  • The upside potential (average analyst target price relative to current price) of IMAB is greater than 21.95% of Pharmaceutical Products stocks.
  • I-Mab's percent of analysts bearish on the stock is lower than almost 100% of all US stocks.
  • IMAB has a greater percentage of analysts bullish on the stock than nearly none of all US stocks.
  • The change in bullishness amongst analysts of IMAB is less than almost 100% of all US stocks.

Is IMAB a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.6097 seconds.